About Us

“We founded IQopta at Copenhagen’s Cluster for Molecular Imaging (CMI) and Rigshospitalet to remove a recurring bottleneck across the full lifecycle from drug development to clinical routine: image analysis was throttling the science. We didn’t want to build yet another piece of software for specialists to learn — we wanted to put an AI layer underneath the workflows clinicians and researchers already trust.”
Andreas Clemmensen
Andreas ClemmensenCo-founder & CEO

Our Team

Academic roots, commercial drive. Our team trained at DTU, UCPH, Stanford and KTH, and pairs that research depth with 15 years of bringing software products to market. We stay close to the cutting edge of deep learning and put it to work on one concrete problem: faster, smarter image analysis from drug development to clinical routine.

We are already collaborating with leading academic groups and industry partners across nuclear medicine and radiopharmaceutical drug development, making IQopta the next step toward faster, smarter medical image analysis.